EPISODE · Nov 21, 2025 · 43 MIN
The EPOch of Treatment Innovation: Triumphs and Pitfalls of Government, Big Pharma, and Nephrology in the Development of rEPO
from ASN Podcast · host American Society of Nephrology
Host Andrew Cohen, MD, discusses the advent of recombinant erythropoietin (rEPO) and its impact on kidney care with Paul Kimmel, MD, FASN; Daniel Coyne, MD; and Ajay Singh, MD.
Embed this episode
Ready to play
The EPOch of Treatment Innovation: Triumphs and Pitfalls of Government, Big Pharma, and Nephrology in the Development of rEPO
0:00
43:12
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of ASN Podcast?
This episode is 43 minutes long.
When was this ASN Podcast episode published?
This episode was published on November 21, 2025.
Is there a transcript available for this episode?
Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.
Can I download this ASN Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!